Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale

• André Golldack,

  Affiliation Pharmaceutical Institute, Christian-Albrechts-University, Kiel, Germany

  ⨯
• Björn Henke,

  Affiliation Pharmaceutical Institute, Christian-Albrechts-University, Kiel, Germany

  ⨯
• Bärbel Bergmann,

  Affiliation Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany

  http://orcid.org/0000-0002-1869-3533

  ⨯
• Marie Wiechert,

  Affiliation Pharmaceutical Institute, Christian-Albrechts-University, Kiel, Germany

  ⨯
• Holger Erler,

  Affiliation Pharmaceutical Institute, Christian-Albrechts-University, Kiel, Germany

  http://orcid.org/0000-0001-5780-8703

  ⨯
• Alexandra Blancke Soares,

  Affiliation Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany

  ⨯
• Tobias Spielmann,

  Affiliation Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany

  http://orcid.org/0000-0002-3968-4601

  ⨯
• Eric Beitz

  * E-mail: ebeitz@pharmazie.uni-kiel.de

  Affiliation Pharmaceutical Institute, Christian-Albrechts-University, Kiel, Germany

  http://orcid.org/0000-0001-5912-6626

  ⨯